MTOR and acute myeloid leukemia: Although mTOR inhibitors as monotherapy showed only a limited efficacy on AML [128,129], dual PI3K/mTOR inhibitors (e.g., NVP-BEZ235, NVPBGT226, and PI-103) induced the cell cycle arrest and apoptosis of leukemic cell lines in preclinical studies [130,131,132].